Author:
Doneski Leon,Roos David,Dong Michael
Abstract
Good Laboratory Practice (GLP) is a regulatory requirement to help ensure the quality, reliability, and integrity of pharmacological and toxicological studies during drug development. This article overviews GLP regulations and related public standards, focusing on practices relevant to analytical and bioanalytical chemists.
Publisher
Multimedia Pharma Sciences, LLC
Reference30 articles.
1. Hill, R. G.; Rang H. P. (Eds). Drug Discovery and Development: Technology in Transition, 2nd ed., Elsevier, 2012.
2. Dong, M. W. Drug Development Process: Nonclinical Development of Small Molecule Drugs, LCGC North Am. 2022, 40 (10), 484–492. DOI: 10.56530/lcgc.na.lz5690w8
3. Doneski, L., Dong, M. W. Pharmaceutical Regulations: An Overview for the Analytical Chemist, LCGC North Am. 2023, 41 (6), 211–215. DOI: 10.56530/lcgc.na.ua3181v7
4. Code of Federal Regulations, Title 21, Part 58, Good Laboratory Practice for Nonclinical Laboratory Studies, Government Publishing Office, https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-58
5. Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Market Authorization for Pharmaceuticals. US FDA, 2019.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献